IDEAYA BIOSCIENCE DL-01
Healthcare · EUR · F
Price
€25.229
Cap
€2.49B
Earnings
—
30d Trend
-6.2%
44% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 45×Macro 0.99 (−1%)=45
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 80%
BRAIN47 HORIZON ANALYSIS
Limited short-term thesis
BRAIN47'S ASSESSMENT
I rate IDEAYA BIOSCIENCE DL-01 at 45/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is momentum at 57/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.
PAST PERFORMANCE
1 MONTH
+4.6%
3 MONTHS
-8.9%
12 MONTHS
+46.3%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Limited short-term thesis. Momentum (57) and Technical (50) are the primary strengths. I note that quality is the weakest area at 34/100 — this warrants monitoring. Historical volatility is elevated at 44%. I classify this as a speculative position — elevated volatility at 44% and asymmetric payoff potential define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.